Skip to main content

Table 3 Mean (SD) or median (interquartile interval) values of variables and variation after 9 months of intervention according to IL6 -174 G/C SNP genotypes

From: Associations of the TNF-alpha -308 G/A, IL6 -174 G/C and AdipoQ 45 T/G polymorphisms with inflammatory and metabolic responses to lifestyle intervention in Brazilians at high cardiometabolic risk

 

GG (n = 47)

GC + CC (n = 86)

 

Baseline

9 months

p

Baseline

9 months

p

Energy intake (Kcal/day)

1748(729.6)

1481(588.0)

.002

1849(649.8)

1574(549.7)

.001

Total physical activity (min/wk)

140(60, 282)

240(70, 330)

.001

160(60, 260)

210(70, 290)

.001

Weight (kg)

76.9(15.3)

74.7(15.6)

.003

78.8(15.7)

77.2(15.3)

.001

Waist circumference (cm)

97.2(10.7)

95.7(11.1)

.036

99.4(12.8)

98.8(12.3)

.161

Fasting glucose (mg/dL)

99.4(11.4)

95.3(11.9)

.038

98.9(11.3)

97.1(12.8)

.233

Triglycerides (mg/dL)

161.1(60.3)

163.9(84.1)

.786

151.5(69.5)

145.3(65.1)

.299

Total cholesterol (mg/dL)

198.3(45.8)

209.5(42.7)

.122

202.9(42.9)

191.5(43.2)†

.011

HDL-c (mg/dL)

44.3(15.5)

45.6(13.6)

.446

41.6(10.5)

47.2(12.1)

.002

LDL-c (mg/dL)

123.1(42.7)

131.8(37.1)

.251

129.4(38.9)

115.5(38.6)†

.002

Apolipoprotein B (mg/dL)

95.6(23.2)

85.1(24.5)

.003

95.6(22.6)

84.1(24.0)

.001

Apolipoprotein A1 (mg/dL)

140.7(22.8)

143.6(24.7)

.197

134.3(15.9)

139.8(16.8)

.001

Insulin* (uUl/L)

8.1(5.4, 11.4)

5.7(4.0, 9.1)

.004

9.7(5.6, 12.1)

7.0(4.3, 10.6)

.002

Adiponectin* (ng/dL)

11.8(7.8, 19.3)

13.1(9.8, 19.7)

.091

12.1(7.3, 18.6)

16.8(12.4, 19.8)

.005

Interleukin 6* (pg/dL)

1.7(0.9, 3.5)

2.8(2.0, 5.4)

.007

2.5(1.4, 4.6)

3.6(2.0, 5.8)

.027

C-reactive protein* (mg/dL)

0.33(0.10, 0.59)

0.25(0.06, 0.64)

.005

0.37(0.19, 0.58)

0.25(0.07, 0.56)

.005

TNF-α** (pg/dL)

11.0(9.0, 13.7)

8.9(6.9, 10.5)

.017

11.0(9.4, 13.3)

8.8(7.2, 10.6)

.016

  1. *Log-transformed for analysis.
  2. **Non-parametric test.
  3. † p < 0.05 versus GG.
  4. TNF-α: Tumor necrosis factor alpha.